The crystal structure of iC3b-CR3 αI reveals a modular recognition of the main opsonin iC3b by the CR3 integrin receptor.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
12 04 2022
Historique:
received: 05 10 2020
accepted: 15 03 2022
entrez: 13 4 2022
pubmed: 14 4 2022
medline: 15 4 2022
Statut: epublish

Résumé

Complement activation on cell surfaces leads to the massive deposition of C3b, iC3b, and C3dg, the main complement opsonins. Recognition of iC3b by complement receptor type 3 (CR3) fosters pathogen opsonophagocytosis by macrophages and the stimulation of adaptive immunity by complement-opsonized antigens. Here, we present the crystallographic structure of the complex between human iC3b and the von Willebrand A inserted domain of the α chain of CR3 (αI). The crystal contains two composite interfaces for CR3 αI, encompassing distinct sets of contiguous macroglobulin (MG) domains on the C3c moiety, MG1-MG2 and MG6-MG7 domains. These composite binding sites define two iC3b-CR3 αI complexes characterized by specific rearrangements of the two semi-independent modules, C3c moiety and TED domain. Furthermore, we show the structure of iC3b in a physiologically-relevant extended conformation. Based on previously available data and novel insights reported herein, we propose an integrative model that reconciles conflicting facts about iC3b structure and function and explains the molecular basis for iC3b selective recognition by CR3 on opsonized surfaces.

Identifiants

pubmed: 35413960
doi: 10.1038/s41467-022-29580-2
pii: 10.1038/s41467-022-29580-2
pmc: PMC9005620
doi:

Substances chimiques

CD11b Antigen 0
Macrophage-1 Antigen 0
Opsonin Proteins 0
Complement C3b 80295-43-8
Complement System Proteins 9007-36-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1955

Informations de copyright

© 2022. The Author(s).

Références

Fernández, F. J., Gómez, S. & Vega, M. C. Pathogens’ toolbox to manipulate human complement. Semin. Cell Dev. Biol. 85, 98–109 (2019).
pubmed: 29221973 doi: 10.1016/j.semcdb.2017.12.001
Ermert, D., Ram, S. & Laabei, M. The hijackers guide to escaping complement: lessons learned from pathogens. Mol. Immunol. 114, 49–61 (2019).
pubmed: 31336249 doi: 10.1016/j.molimm.2019.07.018
Ross, G. D., Lambris, J. D., Cain, J. A. & Newman, S. L. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. J. Immunol. 129, 2051–2060 (1982).
pubmed: 6214588
Ross, G. D. et al. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin. J. Exp. Med. 158, 334–352 (1983).
pubmed: 6224880 pmcid: 2187331 doi: 10.1084/jem.158.2.334
Walport, M. J. Complement. First of two parts. N. Engl. J. Med. 344, 1058–1066 (2001).
pubmed: 11287977 doi: 10.1056/NEJM200104053441406
Walport, M. J. Complement. Second of two parts. N. Engl. J. Med. 344, 1140–1144 (2001).
pubmed: 11297706 doi: 10.1056/NEJM200104123441506
Carroll, M. C. The complement system in regulation of adaptive immunity. Nat. Immunol. 5, 981–986 (2004).
pubmed: 15454921 doi: 10.1038/ni1113
Hawlisch, H. & Köhl, J. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol. Immunol. 43, 13–21 (2006).
pubmed: 16019071 doi: 10.1016/j.molimm.2005.06.028
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V. & Roumenina, L. T. Complement system part II: role in immunity. Front. Immunol. 6, 257 (2015).
pubmed: 26074922 pmcid: 4443744 doi: 10.3389/fimmu.2015.00257
Bajic, G., Yatime, L., Sim, R. B., Vorup-Jensen, T. & Andersen, G. R. Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc. Natl Acad. Sci. USA 110, 16426–16431 (2013).
pubmed: 24065820 pmcid: 3799375 doi: 10.1073/pnas.1311261110
Gahmberg, C. G., Tolvanen, M. & Kotovuori, P. Leukocyte adhesion–structure and function of human leukocyte β2-integrins and their cellular ligands. Eur. J. Biochem. 245, 215–232 (1997).
pubmed: 9151947 doi: 10.1111/j.1432-1033.1997.00215.x
Anderson, D. C. & Springer, T. A. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu. Rev. Med. 38, 175–194 (1987).
pubmed: 3555290 doi: 10.1146/annurev.me.38.020187.001135
Hanna, S. & Etzioni, A. Leukocyte adhesion deficiencies. Ann. N. Y. Acad. Sci. 1250, 50–55 (2012).
pubmed: 22276660 doi: 10.1111/j.1749-6632.2011.06389.x
Tang, T. et al. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 186, 1853–1863 (1997).
pubmed: 9382884 pmcid: 2211718 doi: 10.1084/jem.186.11.1853
Janssen, B. J. C., Christodoulidou, A., McCarthy, A., Lambris, J. D. & Gros, P. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444, 213–216 (2006).
pubmed: 17051160 doi: 10.1038/nature05172
Gros, P., Milder, F. J. & Janssen, B. J. C. Complement driven by conformational changes. Nat. Rev. Immunol. 8, 48–58 (2008).
pubmed: 18064050 doi: 10.1038/nri2231
Papanastasiou, M. et al. Structural Implications for the Formation and Function of the Complement Effector Protein iC3b. J. Immunol. 198, 3326–3335 (2017).
pubmed: 28258193 doi: 10.4049/jimmunol.1601864
Nishida, N., Walz, T. & Springer, T. A. Structural transitions of complement component C3 and its activation products. Proc. Natl Acad. Sci. USA 103, 19737–19742 (2006).
pubmed: 17172439 pmcid: 1750921 doi: 10.1073/pnas.0609791104
Alcorlo, M. et al. Unique structure of iC3b resolved at a resolution of 24 Å by 3D-electron microscopy. Proc. Natl Acad. Sci. USA 108, 13236–13240 (2011).
pubmed: 21788512 pmcid: 3156172 doi: 10.1073/pnas.1106746108
Xu, S., Wang, J., Wang, J.-H. & Springer, T. A. Distinct recognition of complement iC3b by integrins α
pubmed: 28292891 pmcid: 5380021 doi: 10.1073/pnas.1620881114
Taniguchi-Sidle, A. & Isenman, D. E. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 α’-chain. J. Immunol. 153, 5285–5302 (1994).
pubmed: 7963581
Janssen, B. J. C. & Gros, P. Structural insights into the central complement component C3. Mol. Immunol. 44, 3–10 (2007).
pubmed: 16875735 doi: 10.1016/j.molimm.2006.06.017
Aloy, P., Ceulemans, H., Stark, A. & Russell, R. B. The relationship between sequence and interaction divergence in proteins. J. Mol. Biol. 332, 989–998 (2003).
pubmed: 14499603 doi: 10.1016/j.jmb.2003.07.006
Sen, M., Yuki, K. & Springer, T. A. An internal ligand-bound, metastable state of a leukocyte integrin, α
pubmed: 24385486 pmcid: 3840939 doi: 10.1083/jcb.201308083
Sen, M. & Springer, T. A. Leukocyte integrin α
pubmed: 26936951 pmcid: 4801256 doi: 10.1073/pnas.1601379113
Mosca, R. & Schneider, T. R. RAPIDO: a web server for the alignment of protein structures in the presence of conformational changes. Nucleic Acids Res. 36, W42–W46 (2008).
pubmed: 18460546 pmcid: 2447786 doi: 10.1093/nar/gkn197
Vorup-Jensen, T. et al. Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin α
pubmed: 15665082 pmcid: 547869 doi: 10.1073/pnas.0409057102
Vorup-Jensen, T., Ostermeier, C., Shimaoka, M., Hommel, U. & Springer, T. A. Structure and allosteric regulation of the α
pubmed: 12554829 pmcid: 149926 doi: 10.1073/pnas.0237387100
Sarrias, M. R. et al. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J. Immunol. 167, 1490–1499 (2001).
pubmed: 11466369 doi: 10.4049/jimmunol.167.3.1490
Paterson, J. M. et al. Atomic-resolution crystal structures of the immune protein conglutinin from cow reveal specific interactions of its binding site with N-acetylglucosamine. J. Biol. Chem. 294, 17155–17165 (2019).
pubmed: 31562242 pmcid: 6851296 doi: 10.1074/jbc.RA119.010271
Lim, B. L. & Holmskov, U. Expression of the carbohydrate recognition domain of bovine conglutinin and demonstration of its binding to iC3b and yeast mannan. Biochem. Biophys. Res. Commun. 218, 260–266 (1996).
pubmed: 8573143 doi: 10.1006/bbrc.1996.0046
Crispin, M. D. M. et al. Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure. FEBS Lett. 566, 270–274 (2004).
pubmed: 15147907 doi: 10.1016/j.febslet.2004.04.045
Hirani, S., Lambris, J. D. & Müller-Eberhard, H. J. Structural analysis of the asparagine-linked oligosaccharides of human complement component C3. Biochem. J. 233, 613–616 (1986).
pubmed: 3954758 pmcid: 1153071 doi: 10.1042/bj2330613
Young, N. M. & Leon, M. A. The carbohydrate specificity of conglutinin and its homology to proteins in the hepatic lectin family. Biochem. Biophys. Res. Commun. 143, 645–651 (1987).
pubmed: 3566740 doi: 10.1016/0006-291X(87)91402-1
Zhang, H., Li, X.-J., Martin, D. B. & Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 660–666 (2003).
pubmed: 12754519 doi: 10.1038/nbt827
Lewandrowski, U., Moebius, J., Walter, U. & Sickmann, A. Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol. Cell. Proteom. 5, 226–233 (2006).
doi: 10.1074/mcp.M500324-MCP200
Liu, T. et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res. 4, 2070–2080 (2005).
pubmed: 16335952 pmcid: 1850943 doi: 10.1021/pr0502065
Chen, R. et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 8, 651–661 (2009).
pubmed: 19159218 doi: 10.1021/pr8008012
de Bruijn, M. H. & Fey, G. H. Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl Acad. Sci. USA 82, 708–712 (1985).
pubmed: 2579379 pmcid: 397115 doi: 10.1073/pnas.82.3.708
Changede, R. & Sheetz, M. Integrin and cadherin clusters: A robust way to organize adhesions for cell mechanics. Bioessays 39, 1–12 (2017).
pubmed: 27930828 doi: 10.1002/bies.201600123
Sun, Z., Costell, M. & Fässler, R. Integrin activation by talin, kindlin and mechanical forces. Nat. Cell Biol. 21, 25–31 (2019).
pubmed: 30602766 doi: 10.1038/s41556-018-0234-9
Gaither, T. A., Vargas, I., Inada, S. & Frank, M. M. The complement fragment C3d facilitates phagocytosis by monocytes. Immunology 62, 405–411 (1987).
pubmed: 3499379 pmcid: 1454118
Juanhuix, J. et al. Developments in optics and performance at BL13-XALOC, the macromolecular crystallography beamline at the ALBA synchrotron. J. Synchrotron Radiat. 21, 679–689 (2014).
pubmed: 24971961 pmcid: 4073956 doi: 10.1107/S160057751400825X
Duran, D. et al. PROXIMA 2A—a new fully tunable micro-focus beamline for macromolecular crystallography. J. Phys.: Conf. Ser. 425, 012005 (2013).
Kabsch, W. XDS. Acta Crystallogr. D: Biol. Crystallogr. 66, 125–132 (2010).
Winter, G. et al. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr. D: Struct. Biol. 74, 85–97 (2018).
doi: 10.1107/S2059798317017235
Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D: Biol. Crystallogr. 69, 1204–1214 (2013).
doi: 10.1107/S0907444913000061
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D: Biol. Crystallogr. 67, 235–242 (2011).
doi: 10.1107/S0907444910045749
Karplus, P. A. & Diederichs, K. Linking crystallographic model and data quality. Science 336, 1030–1033 (2012).
pubmed: 22628654 pmcid: 3457925 doi: 10.1126/science.1218231
Karplus, P. A. & Diederichs, K. Assessing and maximizing data quality in macromolecular crystallography. Curr. Opin. Struct. Biol. 34, 60–68 (2015).
pubmed: 26209821 pmcid: 4684713 doi: 10.1016/j.sbi.2015.07.003
Wang, J. & Wing, R. A. Diamonds in the rough: a strong case for the inclusion of weak-intensity X-ray diffraction data. Acta Crystallogr. D: Biol. Crystallogr. 70, 1491–1497 (2014).
doi: 10.1107/S1399004714005318
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
pubmed: 19461840 pmcid: 2483472 doi: 10.1107/S0021889807021206
Adams, P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods 55, 94–106 (2011).
pubmed: 21821126 pmcid: 3193589 doi: 10.1016/j.ymeth.2011.07.005
Janssen, B. J. C. et al. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505–511 (2005).
pubmed: 16177781 doi: 10.1038/nature04005
Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D: Biol. Crystallogr. 68, 352–367 (2012).
doi: 10.1107/S0907444912001308
Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D: Biol. Crystallogr. 67, 355–367 (2011).
doi: 10.1107/S0907444911001314
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D: Biol. Crystallogr. 66, 486–501 (2010).
doi: 10.1107/S0907444910007493
Pernot, P. et al. Upgraded ESRF BM29 beamline for SAXS on macromolecules in solution. J. Synchrotron Radiat. 20, 660–664 (2013).
pubmed: 23765312 pmcid: 3943554 doi: 10.1107/S0909049513010431
Round, A. et al. BioSAXS Sample Changer: a robotic sample changer for rapid and reliable high-throughput X-ray solution scattering experiments. Acta Crystallogr. D: Biol. Crystallogr. 71, 67–75 (2015).
doi: 10.1107/S1399004714026959
Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 4, 435–447 (2008).
pubmed: 26620784 doi: 10.1021/ct700301q
Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
pubmed: 29067766 doi: 10.1002/pro.3330
Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98, 10037–10041 (2001).
pubmed: 11517324 pmcid: 56910 doi: 10.1073/pnas.181342398

Auteurs

Francisco J Fernández (FJ)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain. fjfernandez@abvance.com.
Abvance Biotech srl, 28003, Madrid, Spain. fjfernandez@abvance.com.

Jorge Santos-López (J)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain.

Rubén Martínez-Barricarte (R)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Enfermedades Raras, 28040, Madrid, Spain.
Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.

Javier Querol-García (J)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain.
Abvance Biotech srl, 28003, Madrid, Spain.

Héctor Martín-Merinero (H)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Enfermedades Raras, 28040, Madrid, Spain.

Sergio Navas-Yuste (S)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain.

Martin Savko (M)

Synchrotron SOLEIL, L'Orme des Merisiers Saint-Aubin, 91192, Gif-sur-Yvette, France.

William E Shepard (WE)

Synchrotron SOLEIL, L'Orme des Merisiers Saint-Aubin, 91192, Gif-sur-Yvette, France.

Santiago Rodríguez de Córdoba (S)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Enfermedades Raras, 28040, Madrid, Spain.

M Cristina Vega (MC)

Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas, 28040, Madrid, Spain. cvega@cib.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH